Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study
- PMID: 33484783
- PMCID: PMC7817391
- DOI: 10.1016/j.jhin.2021.01.006
Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study
Abstract
It can be a diagnostic challenge to identify patients with coronavirus disease 2019 in whom antibiotics can be safely withheld. This study evaluated the effectiveness of a guideline implemented at Sheffield Teaching Hospitals NHS Foundation Trust that recommends withholding antibiotics in patients with low serum procalcitonin (PCT), defined as ≤0.25 ng/mL. Results showed reduced antibiotic consumption in patients with PCT ≤0.25 ng/mL with no increase in mortality, alongside a reduction in subsequent carbapenem prescriptions during admission. The results support the effectiveness of this guideline, and further research is recommended to identify the optimal cut-off value for PCT in this setting.
Keywords: Antimicrobial stewardship; Bacterial co-infection; COVID-19; Procalcitonin; SARS-CoV-2; Superadded infection.
Crown Copyright © 2021. Published by Elsevier Ltd. All rights reserved.
Figures
Comment in
-
Single-centre experience of using procalcitonin to guide antibiotic therapy in COVID-19 intensive care patients.J Hosp Infect. 2022 Jan;119:194-195. doi: 10.1016/j.jhin.2021.10.010. Epub 2021 Oct 15. J Hosp Infect. 2022. PMID: 34656662 Free PMC article. No abstract available.
References
-
- National Institute for Health and Care Excellence . NICE; London: 2020. COVID-19 rapid guideline: antibiotics for pneumonia in adults in hospital. NICE Guideline 173. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
